Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
OCUP | US
-0.01
-0.78%
Healthcare
Biotechnology
30/06/2024
17/10/2024
1.27
1.27
1.29
1.25
Ocuphire Pharma Inc. a clinical-stage ophthalmic biopharmaceutical company focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops a once-daily preservative-free eye drop formulation of phentolamine mesylate for dim light or night vision disturbances; and for pharmacologically induced mydriasis and presbyopia. The company also develops APX3330 a twice-a-day oral tablet to target pathways relevant to retinal and choroidal vascular diseases such as diabetic retinopathy and diabetic macular edema; and APX2009 and APX2014 second generation preclinical product candidates and analogs of APX3330. The company is headquartered in Farmington Hills Michigan.
View LessLow Market Beta (-0.4 to 0.8)
Value Stock (Price to Book < 3)
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
33.8%1 month
53.9%3 months
68.8%6 months
70.7%-
12.00
0.79
-
-
-2.55
0.20
-
-15.07M
33.54M
33.54M
-
-748.92
-
-69.70
-36.01
10.10
3.74
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.18
Range1M
0.28
Range3M
1.03
Rel. volume
0.52
Price X volume
61.47K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Lantern Pharma Inc. | LTRN | Biotechnology | 3.39 | 36.49M | -3.14% | n/a | 0.71% |
Enlivex Therapeutics Ltd | ENLV | Biotechnology | 1.63 | 34.89M | -3.55% | n/a | 2.92% |
QNCX | QNCX | Biotechnology | 0.7929 | 34.31M | -3.19% | n/a | 30.62% |
OKYO Pharma Limited | OKYO | Biotechnology | 1.01 | 34.17M | -3.81% | n/a | -107.88% |
Moolec Science SA Ordinary Shares | MLEC | Biotechnology | 0.89 | 33.34M | -3.26% | n/a | 209.19% |
Dyadic International Inc | DYAI | Biotechnology | 1.13 | 33.31M | -2.59% | n/a | 175.64% |
Acasti Pharma Inc | ACST | Biotechnology | 3.2816 | 33.28M | -2.04% | n/a | 0.00% |
Acurx Pharmaceuticals Inc. Common Stock | ACXP | Biotechnology | 2.02 | 32.82M | -1.46% | n/a | 0.00% |
Curis Inc | CRIS | Biotechnology | 5.34 | 31.93M | 0.56% | n/a | -6039.91% |
Longeveron Inc. Class A Common Stock | LGVN | Biotechnology | 2.21 | 31.73M | 10.50% | n/a | 11.72% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 12.6 | 19.19M | 0.80% | n/a | 204.46% |
ILAG | ILAG | Building Products & Equipment | 0.98 | 17.70M | -3.92% | n/a | 5.48% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.5763 | 8.36M | -11.91% | 0.04 | 16.03% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.2111 | 3.79M | 2.93% | n/a | 0.97% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.04 | 2.71M | -4.59% | n/a | 9.62% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.0114 | 1.02M | 14.00% | n/a | -37.05% |
Winnebago Industries Inc | WGO | Recreational Vehicles | 60.16 | 0 | -0.43% | n/a | |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 4.3 | 0 | 2.14% | n/a | |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.535 | 0 | 7.00% | n/a | |
Urban One Inc | UONEK | Broadcasting - Radio | 1.07 | 0 | 1.90% | n/a |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -2.55 | 0.53 | Cheaper |
Ent. to Revenue | 0.20 | 4,005.99 | Cheaper |
PE Ratio | - | 40.42 | - |
Price to Book | 0.79 | 15.30 | Cheaper |
Dividend Yield | - | 2.20 | - |
Std. Deviation (3M) | 68.80 | 72.92 | Par |
Debt to Equity | - | -1.24 | - |
Debt to Assets | - | 0.25 | - |
Market Cap | 33.54M | 3.78B | Emerging |